+1-650-457-5617meetings@svicenter.com
+1-650-457-5617
meetings@svicenter.com

Visit BioAge

Developer of drugs designed to impact human aging

Select Meeting Details
BioAge

Extra services

We will confirm the details of your meeting after it is accepted by the host company

Developer of drugs designed to impact human aging. The company's anti-aging drugs are developed by coupling genomics data with machine learning to measure human aging, enabling people to combat the suffering and disability caused by all aging-related diseases and restore both the quality and quantity of life in old age.

Year Founded
2015
General Information
  • Website

    http://bioagelabs.com

  • Business Status

    Generating Revenue

  • Ownership Status

    Privately Held (backing)

  • Financing Status

    Venture Capital-Backed

BioAge's Verticals
BioAge Primary Industry Sector / Group / Code
BioAge Status

The company raised $10.9 million of Series A venture funding in a deal led by Andreessen Horowitz on July 28, 2017, putting the company's pre-money valuation at $32.7 million. Felicis Ventures, AME Cloud Ventures, Pear, Caffeinated Capital, Elad Gil, Farzad Nazem and other undisclosed investors also participated in the round. The company will use the funds to build the team, refine and test its signatures of aging and begin in vivo evaluation of drug candidates.

BioAge Metrics
SimilarWeb Unique Visitors
Headquarters
Get Directions
  • HQ City
    Berkeley
  • HQ State/Province
    California
  • HQ Country
    United States
mood_bad
  • No comments yet.
    • chat
    Add a review

    Leave a Reply ·

    mood_bad
  • Feed is empty.

    • You May Also Be Interested In